275 related articles for article (PubMed ID: 32422442)
21. Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
Makam RCP; Hoaglin DC; McManus DD; Wang V; Gore JM; Spencer FA; Pradhan R; Tran H; Yu H; Goldberg RJ
PLoS One; 2018; 13(5):e0197583. PubMed ID: 29795629
[TBL] [Abstract][Full Text] [Related]
22. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis.
Wang TF; Carrier M; Fournier K; Siegal DM; Le Gal G; Delluc A
Thromb Haemost; 2022 May; 122(5):830-841. PubMed ID: 34399433
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and Safety of Direct Oral Anticoagulants Among Octogenarians with Venous Thromboembolism: An International Multidatabase Cohort Study.
Douros A; Basedow F; Cui Y; Dimakos J; Walker J; Enders D; Tagalakis V
Am J Med; 2023 Jan; 136(1):79-87.e7. PubMed ID: 36150513
[TBL] [Abstract][Full Text] [Related]
24. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
[TBL] [Abstract][Full Text] [Related]
25. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis.
Vedovati MC; Giustozzi M; Bonitta G; Agnelli G; Becattini C
Thromb Res; 2018 Oct; 170():175-180. PubMed ID: 30196195
[TBL] [Abstract][Full Text] [Related]
27. Bleeding Outcomes of Direct Oral Anticoagulants and Vitamin K Antagonists for Acute Venous Thromboembolism: A Cross-Sectional Study.
Javaid Z; Awan SA; Babar M; Khawaja I; Qamar Z
Cureus; 2024 May; 16(5):e60616. PubMed ID: 38894767
[TBL] [Abstract][Full Text] [Related]
28. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.
Vasanthamohan L; Boonyawat K; Chai-Adisaksopha C; Crowther M
J Thromb Haemost; 2018 Jul; 16(7):1288-1295. PubMed ID: 29772108
[TBL] [Abstract][Full Text] [Related]
29. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism.
Fang MC; Reynolds K; Fan D; Prasad PA; Sung SH; Portugal C; Garcia E; Go AS
JAMA Netw Open; 2023 Aug; 6(8):e2328033. PubMed ID: 37581888
[TBL] [Abstract][Full Text] [Related]
30. Trajectories of Oral Anticoagulation Adherence and Associated Clinical Outcomes During Long-Term Anticoagulation Among Medicare Beneficiaries With Venous Thromboembolism.
Park H; Jones BL; Huang PL; Kang HR; Dietrich EA; DeRemer CE; Lo-Ciganic WH
Ann Pharmacother; 2023 Dec; 57(12):1349-1360. PubMed ID: 36999519
[TBL] [Abstract][Full Text] [Related]
31. Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism.
López-Núñez JJ; Pérez-Andrés R; Di Micco P; Schellong S; Gómez-Cuervo C; Sahuquillo JC; Ciammaichella M; Morales MDV; Bosevski M; Monreal M;
TH Open; 2019 Jan; 3(1):e67-e76. PubMed ID: 31249985
[No Abstract] [Full Text] [Related]
32. Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry.
Cohen O; Kenet G; Levy-Mendelovich S; Tzoran I; Brenner B; De Ancos C; López-Miguel P; Varona JF; Catella J; Monreal M;
J Thromb Thrombolysis; 2024 Apr; 57(4):710-720. PubMed ID: 38491267
[TBL] [Abstract][Full Text] [Related]
33. Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolism.
Kelley D; Wright L; Ohman K; Ferreira J
J Thromb Thrombolysis; 2018 Jul; 46(1):58-61. PubMed ID: 29797208
[TBL] [Abstract][Full Text] [Related]
34. DOACs use in extreme body-weighted patients: results from the prospective START-register.
Guarascio M; Bertù L; Donadini MP; Antonucci E; Palareti G; Ageno W
Intern Emerg Med; 2023 Sep; 18(6):1681-1687. PubMed ID: 37301770
[TBL] [Abstract][Full Text] [Related]
35. Comparative Safety and Effectiveness of Direct Oral Anticoagulants and Warfarin during Chemotherapy in Cancer Patients with Venous Thromboembolism Aged 75 Years or Older: A Nationwide Inpatient Database Study.
Iwai C; Jo T; Konishi T; Kumazawa R; Matsui H; Fushimi K; Yasunaga H
Gerontology; 2023; 69(5):561-570. PubMed ID: 36502790
[TBL] [Abstract][Full Text] [Related]
36. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.
van Es N; Coppens M; Schulman S; Middeldorp S; Büller HR
Blood; 2014 Sep; 124(12):1968-75. PubMed ID: 24963045
[TBL] [Abstract][Full Text] [Related]
37. Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
Chen AC; Rao AS; Oropallo A; Goldhaber SZ; Fluharty ME; Maheshwari U; Carrier M; Turpie AGG; Pieper K; Kayani G; Kakkar AK;
Thromb Res; 2023 Dec; 232():123-132. PubMed ID: 37976732
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
Vedovati MC; Giustozzi M; Becattini C
Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
[TBL] [Abstract][Full Text] [Related]
39. Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
Ogihara Y; Yamashita Y; Morimoto T; Chatani R; Kaneda K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Sakamoto J; Inoue T; Usami S; Chen PM; Togi K; Koitabashi N; Hiramori S; Doi K; Mabuchi H; Tsuyuki Y; Murata K; Takabayashi K; Nakai H; Sueta D; Shioyama W; Dohke T; Sato T; Nishikawa R; Kimura T; Dohi K;
Thromb Res; 2024 Apr; 236():191-200. PubMed ID: 38461613
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
Douros A; Filliter C; Azoulay L; Tagalakis V
Thromb Res; 2021 Jun; 202():128-133. PubMed ID: 33836492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
